| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.9 |